Belgium: UCB completes acquisition of Neurona Therapeutics
Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative…
Belgium: UCB strengthens in IMIDs with acquisition of IMIDomics’ Patient Insight business
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients…